MetaADEDB 2.0 @ LMMD
xylometazoline
(HUCJFAOMUPXHDK-UHFFFAOYSA-N)
Structure
SMILES
Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C
Type(s)
Approved; Investigational
ATC code(s)
R01AA07; R01AB06; S01GA03; S01GA53
Molecular Formula:
C16H24N2
Molecular Weight:
244.375
Log P:
2.9095
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
1
TPSA:
24.39
CAS Number(s):
526-36-3; 1218-35-5
Synonym(s)
1.
xylometazoline
2.
2-(4'-tert-butyl-2',6'-dimethylphenylmethyl)imidazoline
3.
Amidrin
4.
Balkis
5.
Chlorohist-LA
6.
Decongest
7.
Gelonasal
8.
Idasal
9.
Idril N
10.
Imidin
11.
Nasan
12.
NasenGel ratiopharm
13.
NasenSpray ratiopharm
14.
NasenTropfen ratiopharm
15.
Nasengel AL
16.
Nasenspray AL
17.
Nasentropfen AL
18.
Novorin
19.
Otradrops
20.
Otraspray
21.
Otriven
22.
Otrivin
23.
Otrivin Mentol
24.
Rapako
25.
Snup
26.
espa-rhin
27.
schnupfen endrine
28.
stas
29.
xylometazoline hydrochloride
30.
xylometazoline monohydrochloride
External Link(s)
MeSHC009695
PubChem Compound5709
BindingDB30703
50027068
ChEBI10082
CHEMBLCHEMBL312448
DrugBankDB06694
DrugCentral3658
IUPHAR/BPS Guide to PHARMACOLOGY517
KEGGcpd:C07913
dr:D08684
Therapeutic Target DatabaseD0Y4DY
ZINC57534
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug DependenceFAERS: 183
Canada Vigilance: 24
Canada Vigilance
US FAERS
2Incorrect drug administration durationFAERS: 71OFFSIDES
US FAERS
3Intentional drug misuseFAERS: 34OFFSIDES
US FAERS
4OverdoseFAERS: 20
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
5Drug ineffectiveFAERS: 14
Canada Vigilance: 10
Canada Vigilance
US FAERS
6Rebound effectFAERS: 14
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
7AnosmiaFAERS: 13
Canada Vigilance: 3
Canada Vigilance
US FAERS
8Incorrect dose administeredFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
9EpistaxisFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
10Maternal exposure during pregnancyFAERS: 9US FAERS
11Inappropriate schedule of drug administrationFAERS: 8OFFSIDES
US FAERS
12AnxietyFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
13PalpitationsFAERS: 7
Canada Vigilance: 3
Canada Vigilance
US FAERS
14Drug abuseFAERS: 6
Canada Vigilance: 12
Canada Vigilance
US FAERS
15Drug exposure during pregnancyFAERS: 6OFFSIDES
US FAERS
16AgeusiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
17DizzinessFAERS: 5OFFSIDES
US FAERS
18HeadacheFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
19HypersensitivityFAERS: 5US FAERS
20Wrong technique in drug usage processFAERS: 5OFFSIDES
US FAERS
21Incorrect route of drug administrationFAERS: 4US FAERS
22MalaiseFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
23Nasal discomfortFAERS: 4
Canada Vigilance: 3
Canada Vigilance
US FAERS
24PainFAERS: 4
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
25TachycardiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
26Therapeutic response unexpectedFAERS: 4US FAERS
27Diabetes MellitusFAERS: 3US FAERS
28ErythemaFAERS: 3US FAERS
29Feeling abnormalFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
30InfectionFAERS: 3US FAERS
31No adverse drug reactionFAERS: 3US FAERS
32Wrong technique in product usage processFAERS: 3US FAERS
33Accidental drug intake by childFAERS: 2US FAERS
34Application site painFAERS: 2OFFSIDES
US FAERS
35BradycardiaFAERS: 2US FAERS
36Disease recurrenceFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
37DysgeusiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
38InfluenzaFAERS: 2US FAERS
39Myocardial InfarctionFAERS: 2US FAERS
40PregnancyFAERS: 2US FAERS
41RhinitisFAERS: 2
Canada Vigilance: 5
Canada Vigilance
US FAERS
42Sinus ArrhythmiaFAERS: 2US FAERS
43SinusitisFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
44SomnolenceFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
45SyncopeFAERS: 2US FAERS
46TremorFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
47jaundiceFAERS: 2US FAERS
48ArthralgiaFAERS: 1US FAERS
49ArthritisFAERS: 1US FAERS
50AstheniaFAERS: 1OFFSIDES
US FAERS
51Atrial FibrillationFAERS: 1US FAERS
52Blood glucose increasedFAERS: 1US FAERS
53Burning sensationFAERS: 1
Canada Vigilance: 3
Canada Vigilance
US FAERS
54CheilitisFAERS: 1US FAERS
55Chest discomfortFAERS: 1US FAERS
56ClaustrophobiaFAERS: 1US FAERS
57Depressed moodFAERS: 1US FAERS
58Drug administered to patient of inappropriate ageFAERS: 1US FAERS
59Drug dispensing errorFAERS: 1US FAERS
60Drug withdrawal syndromeFAERS: 1US FAERS
61DysphoniaFAERS: 1US FAERS
62DysuriaFAERS: 1US FAERS
63Ear discomfortFAERS: 1US FAERS
64Expired drug administeredFAERS: 1US FAERS
65Expired product administeredFAERS: 1US FAERS
66Eye painFAERS: 1US FAERS
67FatigueFAERS: 1OFFSIDES
US FAERS
68GlaucomaFAERS: 1US FAERS
69Glucose tolerance increasedFAERS: 1US FAERS
70Hepatitis CFAERS: 1US FAERS
71Hernia perforationFAERS: 1US FAERS
72HyperventilationFAERS: 1US FAERS
73Incorrect product storageFAERS: 1US FAERS
74Lip swellingFAERS: 1US FAERS
75Macular degenerationFAERS: 1US FAERS
76Mouth swellingFAERS: 1US FAERS
77Musculoskeletal PainFAERS: 1US FAERS
78MyopiaFAERS: 1US FAERS
79Nasal mucosal disorderFAERS: 1US FAERS
80NasopharyngitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
81No adverse eventFAERS: 1US FAERS
82Optic NeuritisFAERS: 1US FAERS
83PallorFAERS: 1US FAERS
84Panic DisorderFAERS: 1US FAERS
85PoisoningFAERS: 1US FAERS
86Polyneuropathy chronicFAERS: 1US FAERS
87Poor quality sleepFAERS: 1US FAERS
88Positron emission tomogram abnormalFAERS: 1US FAERS
89Product container issueFAERS: 1US FAERS
90Product contaminationFAERS: 1US FAERS
91PruritusFAERS: 1US FAERS
92RestlessnessFAERS: 1US FAERS
93Retinal Artery OcclusionFAERS: 1US FAERS
94ScabFAERS: 1US FAERS
95Skin reactionFAERS: 1US FAERS
96Suicide attemptFAERS: 1US FAERS
97SwellingFAERS: 1US FAERS
98UrticariaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
99Visual ImpairmentFAERS: 1US FAERS
100VomitingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
101Wrong drug administeredFAERS: 1US FAERS
102YawningFAERS: 1US FAERS
103Abnormal visionOFFSIDES
104AbuseOFFSIDES
105Anaphylactic shockCanada Vigilance: 1Canada Vigilance
106AneurysmCanada Vigilance: 1Canada Vigilance
107Application site reactionCanada Vigilance: 2Canada Vigilance
108Arthropod stingCanada Vigilance: 1Canada Vigilance
109Atrial tachycardiaOFFSIDES
110Autoimmune hepatitisOFFSIDES
111Benign Prostatic HyperplasiaOFFSIDES
112BlepharospasmOFFSIDES
113Blood cortisol decreasedOFFSIDES
114Blood creatinine decreasedOFFSIDES
115BronchospasmCanada Vigilance: 1Canada Vigilance
116Catalepsy35781
35783
CTD
117Chest PainCanada Vigilance: 1Canada Vigilance
118Choking sensationOFFSIDES
119Common Cold20030735CTD
120Conjunctival depositOFFSIDES
121CraniotomyOFFSIDES
122DeafnessOFFSIDES
123Decreased LibidoOFFSIDES
124DehydrationCanada Vigilance: 1Canada Vigilance
125DementiaCanada Vigilance: 2Canada Vigilance
126Drug addictOFFSIDES
127Drug ineffective for unapproved indicationCanada Vigilance: 1Canada Vigilance
128Exposure via breast milkCanada Vigilance: 1Canada Vigilance
129FormicationOFFSIDES
130Hepatic necrosisOFFSIDES
131Hormone level abnormalOFFSIDES
132Incorrect product administration durationCanada Vigilance: 3Canada Vigilance
133InflammationCanada Vigilance: 1Canada Vigilance
134Intentional product misuseCanada Vigilance: 1Canada Vigilance
135LethargyCanada Vigilance: 1Canada Vigilance
136Lymphocyte count decreasedOFFSIDES
137Medication ErrorCanada Vigilance: 1Canada Vigilance
138Muscle WeaknessOFFSIDES
139Nasal PolypsCanada Vigilance: 1Canada Vigilance
140NauseaCanada Vigilance: 2Canada Vigilance
141Purulent dischargeCanada Vigilance: 1Canada Vigilance
142Respiratory distressCanada Vigilance: 1Canada Vigilance
143Secondary hypothyroidismOFFSIDES
144SneezingCanada Vigilance: 1Canada Vigilance
145Spinal column stenosisOFFSIDES
146Temperature intoleranceOFFSIDES
147Throat irritationCanada Vigilance: 1Canada Vigilance
148TinnitusOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.